Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health problems news

Show

From To
HIV-related factors increase risk of stroke

HIV-related risk factors seem to increase the risk of stroke – the sudden death of brain cells due to a rupture or obstruction of blood vessels in

Published
15 March 2016
By
Theo Smart
HIV-infected young males have higher rates of bone loss than females

Accumulating evidence suggests that rates of low bone mass are greater in HIV-infected males than in females. Researchers led by Grace Aldrovandi, MD, chief of the Division of Infectious Diseases at Children's Hospital Los Angeles, studied 11 biomarkers associated with inflammation, bone loss and/or bone formation in about 450 individuals -- assessed by sex and HIV status -- to try to determine causes of this differential bone loss.

Published
11 March 2016
From
Eurekalert Medicine & Health
Last Men Standing: The Forgotten Survivors Of AIDS

These men, then in their 20s and 30s, weren’t supposed to make it to 40. Now some are 60 years old, even 70, still alive but wounded physically, psychologically and economically. They also are suffering debilitating health problems, chronic illnesses brought on by a lifetime of living with AIDS and the toxic effects of its treatment. Many live in stark isolation, feeling abandoned and forgotten, even by the gay community they helped build here.

Published
11 March 2016
From
San Francisco Chronicle
First look at big 75-and-older HIV group - diagnosed at age 62

Compared with HIV patients between 50 and 75 years old, those 75 and older had a similar rate of viral suppression but significantly more age-linked noncommunicable comorbidities. This 15-site French study found that 98% of the 75-and-older group were taking antiretroviral therapy.

Published
07 March 2016
From
NATAP
Modest kidney function decline in people taking Truvada for PrEP supports need for monitoring

Participants taking tenofovir/emtricitabine (Truvada) for pre-exposure prophylaxis (PrEP) in two major studies experienced modest declines in kidney function that were associated with higher tenofovir drug levels and older

Published
02 March 2016
By
Liz Highleyman
Study does not support routine HPV quadrivalent vaccination to protect against anal cancer in older people living with HIV

The quadrivalent HPV vaccine Gardasil does not protect older adults with HIV against persistent anal infection with human papillomavirus (HPV) or the development of HSIL, but the

Published
29 February 2016
By
Keith Alcorn
Cardiovascular Risk Tools for HIV Go Head-to-Head in Large U.S. Study

A cardiovascular risk-scoring system known as ASCVD appears to be a better predictor of myocardial infarction (MI) among people with HIV than other risk scores, including Framingham and D:A:D, according to new research.

Published
26 February 2016
From
The Body Pro
Antidepressant May Improve Cognitive Symptoms in People with HIV

In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment.

Published
26 February 2016
From
Hopkins Medicine
Early antiretroviral therapy reduces the risk of infection-related cancers

People who started antiretroviral therapy at a CD4 cell count above 500 had a significantly lower risk of developing a cancer with an infectious cause when compared

Published
25 February 2016
By
Keith Alcorn
HIV in the brain: new tools and treatment to keep your mind beautiful

In the future, HIV-associated neurocognitive disorder (HAND) may become less common because of the earlier use of antiretroviral therapy (ART), but neurological disease – caused by a

Published
25 February 2016
By
Theo Smart

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.